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Ethanol Affects Differentiation-Related Pathways and
Suppresses Wnt Signaling Protein Expression in Human
Neural Stem Cells
Sharada D. Vangipuram and William D. Lyman
Background: Prenatal exposure of the fetus to ethanol (EtOH) can be teratogenic. We previ-
ously showed that EtOH alters the cell fate of human neural stem cells (NSC). As Wnt signaling
plays an important role in fetal brain development, we hypothesized that EtOH suppresses Wnt
signaling protein expression in differentiating NSC and thereby contributes to fetal alcohol spec-
trum disorder.
Methods: NSC isolated from fetal human brains were cultured in mitogenic media to induce
neurospheres, which were dissociated into single-cell suspensions and used for all experiments.
Equal numbers of NSC were cultured on lysine ⁄ laminin-coated plates for 96 hours in differentiat-
ing media containing 0, 20, or 100 mM EtOH. Total mRNA was isolated from samples contain-
ing 0 or 100 mM EtOH and changes in expression of 263 genes associated with neurogenesis and
NSC differentiation were determined by Oligo GEArray technology. The biological impact of
gene changes was estimated using a systems biology approach with pathway express software and
KEGG database. Based on the pathways identiﬁed, expression of Wnt proteins (Wnt3a and
Wnt5a), Wnt-receptor complex proteins (p-LRP6, LRP6, DVL2, and DVL3), Wnt antagonist
Naked-2 (NKD-2), and downstream Wnt proteins (b-catenin, Tyr-p-GSK3b, Ser-p-GSK3b) were
analyzed by Western blot.
Results: Of the 263 genes examined, the expressions of 22 genes in differentiating NSC were
either upwardly or downwardly affected by EtOH. These genes are associated with 5 path-
ways ⁄ cellular processes: axon guidance; hedgehog signaling; TGF-b signaling; cell adhesion mole-
cules; and Wnt signaling. When compared to controls, EtOH, at both 20 and 100 mM
concentrations, suppressed the expression of Wnt3a and Wnt5a, receptor complex proteins
p-LRP6, LRP6 and DVL2, and cytoplasmic proteins Ser-p-GSK3b and b-catenin. Expression of
NKD-2 and DVL3 remained unchanged and the expression of active Tyr-p-GSK3b increased
signiﬁcantly.
Conclusions: EtOH can signiﬁcantly alter neural differentiation pathway-related gene expres-
sion and suppress Wnt signaling proteins in differentiating human NSC.
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E THANOL (EtOH) CONSUMPTION by pregnantwomen can adversely affect the developing fetus result-
ing in a spectrum of deﬁciencies known as fetal alcohol spec-
trum disorder (FASD). Anomalies of FASD include
craniofacial abnormalities and mental retardation in fetal
alcohol syndrome the most severe form of FASD, whereas
milder forms are characterized by behavioral and cognitive
deﬁciencies such as attention deﬁcit hyperactivity and devel-
opmental delay (Jones, 2011; Jones and Smith, 1973; Jones
et al., 1974a,b; Kodituwakku, 2007; Kodituwakku et al.,
2001; Mattson and Riley, 1998; Mattson et al., 1996).
Several mechanisms have been suggested as part of action
of EtOH on the developing fetus as reviewed by Goodlett and
colleagues (2001, 2005). These include disruption of cellular
energy mechanisms such as alterations in glucose and DNA
metabolism (Hu et al., 1995; Singh et al., 1993, 1994; Snyder
and Singh, 1989; Snyder et al., 1992a,b), changes in cell–cell
interactions and adhesion molecules (Bearer et al., 1999; Luo
and Miller, 1999; Min˜ana et al., 1998, 2000; Ramanathan
et al., 1996; Tang et al., 2006; Vangipuram et al., 2008) and
alterations in growth factor and other signaling pathways
(Alfonso-Loeches and Guerri, 2011; Hicks and Miller, 2011;
Lindsley et al., 2011; de la Monte et al., 2011). Recently,
neural stem cells (NSC) and progenitor cells have been the
subjects of studies on EtOH neurotoxicity (Anthony et al.,
2008; Camarillo and Miranda, 2008; Sathyan et al., 2007;
Singh et al., 2009; Vangipuram and Lyman, 2010; Vangipu-
ram et al., 2008; Zhou et al., 2011). We have previously
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shown that EtOH alters the cell fate and cell adhesion mole-
cule (CAM) expression in human fetal brain derived NSC
without increasing apoptosis (Vangipuram and Lyman, 2010;
Vangipuram et al., 2008). Considering the number of possible
mechanisms that could be involved in such an effect, we
conducted an Oligo GEArray Microarray analysis to deter-
mine the differences in transcript levels between control and
EtOH-treated human fetal brain derived NSC. For this study,
we used a microarray that proﬁled the expression of 263 genes
related to regulation of key neurogenesis processes such as
regulators of cell proliferation and differentiation, synaptic
transmission, synaptogenesis, and other key cellular func-
tions.
Wnt signaling pathway plays an important role in embryo-
genesis and neurogenesis (Castelo-Branco and Arenas, 2006;
Cerpa et al., 2009; Freese et al., 2010; Hur and Zhou, 2010;
Smalley and Dale, 1999; Toledo et al., 2008). Wnts are shown
to be essential at various stages of neural development includ-
ing stem cell proliferation and maintenance of progenitor
pool as well as in differentiation and lineage determination.
Wnts are also known to be involved in cell migration, axon
guidance, and neurite outgrowth as reviewed by Ille and Som-
mer (2005). Glycogen synthase kinase3b (GSK3b), a key
component of the Wnt signaling pathway has been shown to
be involved in EtOH-induced neurotoxicity (Liu et al., 2009;
Luo, 2009). Based on our Oligo GEArray analysis and on the
existing data on the possible role of GSK3b in EtOH-induced
neurotoxicity, we hypothesized that EtOH suppresses Wnt
signaling pathway protein expression in fetal human brain
derived NSC under differentiating conditions.
Cell surface markers CD133 ⁄prominin and nestin expres-
sion has been used to deﬁne NSC by several groups including
ours (Hockﬁeld and McKay, 1985; Lendahl et al., 1990; Tate-
no et al., 2004; Uchida et al., 2000; Vangipuram et al., 2008).
To test our hypothesis we utilized CD133 ⁄nestin expression
to select NSC from second trimester fetal human brain. Data
obtained as a part of this study show that EtOH signiﬁcantly
suppresses endogenous levels of Wnt3a and Wnt5a and
related receptor complex and cytoplasmic Wnt pathway
proteins. As expected, EtOH increased Tyr phosphorylation
of GSK3b, which promotes degradation of b-catenin, a key
downstreamWnt signaling pathway protein.
MATERIALS AND METHODS
Isolation of Neural Progenitor Cells
CD133+ ⁄nestin+ NSC were isolated from fetal human brain tis-
sue (14 to 17 weeks of gestation) obtained from the Albert Einstein
College of Medicine, Bronx, NY as previously described (Vangipu-
ram and Lyman, 2010; Vangipuram et al., 2008). This study is part
of an on-going research protocol approved by the human investiga-
tion committee, Wayne State University. Fetal brain tissue was
obtained from voluntary terminations of normal pregnancies and the
fetuses were not known to have been exposed to alcohol or tobacco.
The tissue was washed with Hank’s balanced salt solution and
cleared of meninges. The tissue was diced and triturated and a single-
cell suspension was obtained in serum-free complete NeurocultR
NS-A proliferation medium containing Neurocult NS-A Basal
medium (human), Neurocult NS-A proliferation supplements
(STEMCELL Technologies, Vancouver, BC, Canada), 20 ng ⁄ml
each of hEGF and h-bFGF (Peprotech Inc., Rocky Hill, NJ), and
2 lg ⁄ml of heparin. CD133+ cells (NSC) were positively selected
from the cell suspension using anti-CD133 labeled magnetic
microbeads from the MACS cell isolation kit (Miltenyi Biotechnolo-
gies, Auburn, CA). The purity of the isolated cell population was esti-
mated by ﬂow cytometry using anti-nestin antibody (R&D Systems,
Minneapolis, MN) and anti-CD 133 antibody (Miltenyi Biotechnolo-
gies). Isolated NSC were propagated as neurospheres in 6-well tissue
culture plates at a density of 10 to 12 · 103 cells per well.
Immunophenotyping
Isolated NSC were stained for CD133 and nestin expression as
previously described (Barami et al., 2001; Vangipuram et al., 2008).
Brieﬂy, the cells were incubated with PE or FITC conjugated primary
antibodies (anti-CD133 [Miltenyi Biotechnologies], or anti-nestin
[R&D systems]), in the dark for 20 minutes at room temperature and
ﬁxed with Coulter ﬁxative. A 2 color analysis was performed using a
Coulter XL Flow Cytometer (Coulter Corp, Miami, FL) gated on
the viable cell population as inferred from forward and side scatter
analyses. For cytoplasmic staining of nestin, the protocol described
by Groeneveld and colleagues (1996) was slightly modiﬁed. Brieﬂy,
the cell suspensions were ﬁrst ﬁxed then permeabilized using Caltag’s
FIX and PERM kit (Caltag Labs, Burlingame, CA) according to
manufacturer recommendations. Cells were incubated with isotype
matched controls for all samples.
EtOH Exposure
NSC were isolated from 3 different fetal brain samples and all
experiments were conducted separately for each brain sample. Neur-
ospheres generated from CD133+ NSC were dissociated, character-
ized for CD133 and nestin expression, and used for EtOH exposure.
A total of 10 to 12 · 103 cells were cultured on lysine ⁄ laminin-coated
tissue culture plates in differentiation medium containing Neurocult
NS-A Basal medium (human), Neurocult NS-A differentiation
supplements (STEMCELL Technologies) with 0, 20, or 100 mM
EtOH. Tissue culture plates were placed in saturated EtOH chambers
to mitigate evaporation of EtOH from the culture media (Rodrı´guez
et al., 1992). EtOH containing media were prepared freshly before
use with 200 absolute EtOH. The EtOH dose range was selected
and conﬁrmed to be equivalent to the concentrations of alcohol in
the blood of social drinkers to chronic alcoholics (Adachi et al.,
1991; Perper et al., 1986) and has been used previously by others in
relevant cell culture experiments (Tateno et al., 2004, 2005). The cells
were exposed to EtOH for 96 hours in a humidiﬁed atmosphere con-
taining 5% CO2 at 37C.
Total RNA Isolation
After 96 hours, total RNA was extracted from control and
100 mM EtOH-treated NSC using RNeasy mini kit (Qiagen Inc.,
Valencia, CA) as per the kit manufacturer’s protocol. The quality
and quantity of RNA was assessed using an Agilent Bioanalyzer
(Agilent Technologies, Santa Clara, CA). RNA with RNA Integrity
Number (RIN) > 9 was used for Oligo GEArray DNA Microarray
analysis using human neurogenesis and NSC array (SuperArray Bio-
sciences, Frederick, MD).
Oligo GEArray DNA Microarray Analysis
Human neurogenesis and NSC Oligo GEArray DNA Microarray
was used to determine differential transcript levels between control
and 100 mM EtOH-treated samples (n = 3). The microarray
proﬁled the expression of 263 genes related to regulation of key
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neurogenesis processes. Standard Hyb tube protocol was followed
for the analysis as per the kit manufacturer’s directions. Brieﬂy, 3 lg
of high quality total RNA (RIN > 9) was used to synthesize
complementary C-DNA. True labeling-AMP 2.0 Oligo GEArray
starter kit was used for c-RNA synthesis, ampliﬁcation and biotinyla-
tion. C-RNA was puriﬁed using SuperArray ArrayGrade cRNA
Cleanup Kit. A Nanodrop 1000 spectrophotometer (Thermo
Scientiﬁc Inc., Rockford, IL) was used to assess the c-RNA yield and
quality.
Oligo GEArray Hybridization and Detection
Oligo GEArray membranes were hybridized with 4 lg of biotiny-
lated C-RNA from control and EtOH-treated samples (n = 3) as
per kit manufacturer’s protocol. Brieﬂy, the membranes were prehy-
bridized in hybridization solution for 2 hours at 60C with continu-
ous, but slow agitation, followed by hybridization with C-RNA at
60C, overnight with gentle agitation. The membranes were then
washed and the signals detected using the chemiluminescent detection
kit (SuperArray Biosciences) and digitized using Carestream CCD
camera system (Carestream Health Inc., New Haven, CT). Fold
change (1-fold = 100%) in the expression of genes from EtOH-
treated and control samples were compared using integrated
GEArray expression analysis software. Oligo GEArray Human
Neurogenesis and Neural Stem Cell Microarray from SuperArray
Biosciences contained 263 genes which included positive and negative
regulators of cell proliferation, negative regulators of cell cycle, cell
cycle arrest genes, regulators of cell differentiation, synaptic transmis-
sion, synaptogenesis, apoptosis, and cell adhesion. Further, the array
also included genes involved in neurogenesis such as molecules of
notch signaling, Wnt receptor and G protein-coupled receptor path-
ways. Fold change (1-fold = 100%) in the expression of these genes
from EtOH-treated and control samples were compared using
integrated GEArray expression analysis software. All data sets were
corrected using the lowest density reading of a spot on the array for
background subtraction. After background subtraction, interquartile
value was used for normalization. The interquaritle normalization
option normalizes each spot brightness to the mean intensity value of
all the spots in the middle half (50%) of the range that remains after
ignoring the most and least intense quarter (25%) of the entire data
set. Only genes that showed up or down-regulation of at least 1.5-fold
or more were considered to have been altered by EtOH.
Pathway Analysis
The potential biological impact of changes in gene expression was
estimated using a systems biology approach that employs an impact
analysis method of pathway express software. Pathway express and
OntoExpress analysis software (Draghici et al., 2003; Khatri et al.,
2005) was utilized to estimate the signiﬁcance of gene changes in rela-
tion to biological pathways. Using this method, an impact factor is
calculated for each pathway by incorporating multiple factors such
as the normalized fold change of differentially expressed genes, the
statistical signiﬁcance of the set of pathway genes, and the topology
of the signaling pathway (from KEGG database). Pathways which
showed an impact factor higher than 5 along with a p-value £0.05
were considered to be signiﬁcantly altered.
Western Blot Analysis
Western blot analysis was performed on control and EtOH-treated
samples as previously described (Vangipuram and Lyman, 2010).
CD133+ NSC differentiating in laminin ⁄ lysine-coated 6 well plates
were lysed with NP-40 lysis buffer containing 0.15 M NaCl; 1 mM
EGTA; 1 mg ⁄ml BSA; 10 mM Tris; 1% NP-40; 0.2 mM phenyl-
methylsulfonyl ﬂuoride; 5 mg ⁄ml aprotinin, leupeptin, and pepstatin,
pH 7.4 after washing with ice-cold PBS. Unlysed cells were pelleted
by centrifuging at 13,000·g for 15 minutes at 4C in Beckman mi-
crocentrifuge (Beckman Coulter, Fullerton, CA). The protein con-
centrations of the lysates were determined using the Pierce protein
estimation kit (Thermo Fisher scientiﬁc Inc.). The expression of Wnt
proteins (Wnt3a and Wnt5a), Wnt-receptor complex proteins
(p-LRP6, LRP6, DVL2, and DVL3), Wnt antagonist Naked-2
(NKD-2), and downstream Wnt proteins (b-catenin, Tyr-p-GSK3b,
Ser-p-GSK3b) from the Wnt canonical pathway were analyzed by
Western blot. Brieﬂy, 25 to 30 lg ⁄ lane of protein lysates of all sam-
ples was loaded on 10% sodium dodecyl sulfate polyacrylamide gel
electrophoresis gel, separated by gel electrophoresis, and then trans-
ferred to PVDF membranes. The membranes were washed with
PBS-T and nonspeciﬁc binding was blocked with 5% nonfat dry
milk in PBS-T for 1 hour with shaking. The membranes were then
incubated with primary antibodies (Cell Signaling Technology,
Danvers, MA) overnight with shaking at 4C. Subsequent to wash-
ing, the membranes were incubated with secondary goat anti-rabbit
peroxidase-conjugated antibody for 1 hour at 25C. The membranes
were then developed and visualized with the Pierce ECL Western
blotting substrate (Pierce, Rockford, IL) followed by apposition of
the membranes with autoradiographic Kodak X-OMAT AR ﬁlm
(Rochester, NY). The protein expression was quantiﬁed by digitizing
the ECL signals using Carestream molecular imaging software 5.0.
The bands corresponding to the expected molecular weight were
analyzed for each of the proteins where more than 1 band was
seen (Tyr-p-GSK3b—47 kDa, SER-p-GSK3b—46 kDa, Wnt3a—
42 kDa, b-actin—45 kDa, and NKD-2—59 kDa). In all cases, the
darkest band corresponded to the expected molecular weight.
Statistical Analysis
To examine mean differences in band densities of various proteins
a parametric analysis of variance (ANOVA) procedure was
employed. Assumptions of normality and ⁄or homogeneity of vari-
ance were checked and veriﬁed. Normality was checked using stem
and leaf plots and histograms. Homogeneity of variance was for-
mally checked using Levene’s statistic. Post hoc tests were conducted
using Bonferroni’s correction to balance multiple tests of hypotheses
(pair-wise comparisons) and Type I error. SPSS Version 19.0 (IBM
Inc., Chicago, IL) was used to perform all statistical procedures.
Statistically signiﬁcant differences were considered achieved with a
p-value <0.05.
RESULTS
Generation of Neurospheres from NSC Isolated from
Second Trimester Fetal Human Brain
NSC were isolated from second trimester fetal human brain
by positive immuno-selection. CD 133 and nestin expression
was used to conﬁrm the differentiation state of the cells
(Fig. 1). Neurospheres were generated from these cells in
serum-free mitogenic media in the presence of hEGF and
bFGF as previously described (Vangipuram and Lyman,
2010; Vangipuram et al., 2008) and dissociated for
experiments.
Oligo GEArray Analysis of Control and EtOH-Treated
NSC
Oligo GEArray Human Neurogenesis and Neural Stem
Cell Microarray containing 263 genes related to neurogenesis
and NSC differentiation including 12 housekeeping genes,
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was used to study the effect of EtOH on NSC. The transcript
signals were detected on the membranes by chemiluminiscent
detection system and visualized on Carestream CCD camera.
Using integrated GEArray expression analysis software, 22
genes were identiﬁed to be altered by at least 1.5-fold com-
pared with controls. Of these, 6 genes were up-regulated and
16 genes were down-regulated (Table 1). Of the 263 genes on
the array, 138 genes were absent in the samples (Table S1).
Pathway Express Analysis
The pathway express and OntoExpress analysis software
was used to assign altered genes from the Oligo GEArray
results to speciﬁc biological pathways ⁄cellular processes with
highest impact as described (Draghici et al., 2003; Khatri
et al., 2005). Five pathways ⁄cellular processes were identiﬁed
to have an impact factor greater than 5 and a p-value <0.05,
namely, axon guidance, hedgehog signaling, TGF-b signaling,
CAMs, and Wnt signaling (Table 2). Of the pathways identi-
ﬁed, Wnt signaling pathway was chosen for in-depth study
due to the role played by Wnt signaling in neural develop-
ment and neurogenesis (Cadigan and Nusse, 1997; Toledo
et al., 2008) and in EtOH-induced neurotoxicity (Liu et al.,
2009; Luo, 2009).
Western Blot Analysis of Wnt Signaling Pathway Proteins
Endogenous levels of Wnt proteins Wnt3a and Wnt5a were
ﬁrst estimated by Western blot analysis and band intensities
estimated by densitometry. Expressions levels of both Wnts
studied were signiﬁcantly suppressed in differentiating NSC
with exposure to both 20 and 100 mM concentrations of
1 2
Fig. 1. Two color analysis using a Coulter XL Flow Cytometer on viable neural stem cells (NSC) population showing percentage of cells expressing
CD133 and nestin.
Table 1. List of Genes Altered by Ethanol in Differentiating Neural Stem Cells Determined by Oligo GEArray Analysis
Gene symbol Gene name
Fold expressed
relative to control Function in fetal brain development
HDAC4 Histone deacetylase4 1.78 Involved in TGF-b induced differentiation
HEY1 Hairy ⁄ enhancer-of-split related with
YRPW motif protein 1
1.54 Implicated in neurogenesis and somitogenesis
MDK Midkine-neurite growth promoting factor 2 1.84 Cell proliferation, cell migration, angiogenesis, and fibrinolysis
PBX4 Pre-B cell leukemia homobox-4 1.99 Transcriptipn factor involved in translocations
PCDH1 Protocadherin 3.14 Involved in neural adhesion and development
SPOCK1 Testican 1 3.10 Unknown—possible protease inhibition
ACHE Acetylcholinesterase 0.31 Apoptosis related
APAF1 Apoptotic protease activating factor 1 0.63 Part of apoptosis regulatory network
APBA1 Adapter protein · 11alpha, 0.57 Essential component of synaptic vescicles
APBB2 Amyloid beta A4 precursor protein-binding
family B member 2
0.47 Involved in signal transduction
APLP1 amyloid beta (A4) precursor-like protein 0.32 Role in postsynaptic function
EP300 E1A binding protein p300 0.61 Important role in cell proliferation and differentiation
MT3 Metallothionein-3 0.62 Survival and neurite formation of cortical neurons
NCKAP1 NCK-associated protein 1 0.52 Membrane associated protein
NDP Norrie disease (pseudoglioma) 0.64 Mutations in Norrie Disease
NRCAM Neuronal cell adhesion molecule 0.64 Involved in neuron–neuron adhesion and directional growth
POU6F1 POU class 6 homeobox 0.65
PTN Pleotrophin 0.66 Neurite growth promoting factor
ROBO1 Roundabout homolog 1 0.55 Axon guidance receptor and cell adhesion receptor
SOD1 Superoxide dismutase 1 0.63 Neutralizes supercharged oxygen molecules
SOX3 SRY-related HMG-box 0.64 Cell fate determination
TFAP2B Transcription factor AP-2 beta 0.52 Stimulates cell proliferation and suppresses
terminal differentiation
References for gene functions are available in Data S1. Values showed in bold represent up-regulated genes.
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EtOH (Fig. 2). Subsequently, expression of Wnt receptor
complex proteins, phosphorylated and total LRP6, DVL2,
DVL3, and Wnt antagonist NKD-2 were studied. Although
there was no signiﬁcant change in the expression of NKD-2
and DVL3, expression of phosphorylated LRP6 and DVL2
was signiﬁcantly suppressed by 20 and 100 mM EtOH and
total LRP6 was signiﬁcantly suppressed by 100 mM EtOH
(Fig. 3). Finally, expression of cytoplasmic Wnt proteins,
b-catenin, and GSK3b were studied. As expected, EtOH
signiﬁcantly suppressed the expression levels of b-catenin and
Ser phosphorylated and total GSK3b. Expression of active
Tyr phosphorylated GSK3b which phosphorylates cytoplas-
mic b-catenin leading to its ubiquitination and degradation,
was signiﬁcantly increased with EtOH exposure (Fig. 2).
DISCUSSION
The major ﬁnding of this study is that exposure of differen-
tiating human NSC to EtOH signiﬁcantly alters the levels of
gene transcripts that could potentially impact 5 major cellular
pathways ⁄processes as computed by pathway express soft-
ware analysis. These are: axon guidance, hedgehog signaling,
TGF-b signaling, CAMs, and Wnt signaling (Table 2). Fur-
ther, this study also shows that the key components of the
Wnt signaling pathway are suppressed by EtOH in a dose-
related manner suggesting that Wnt signal suppression could
be a signiﬁcant part of the mechanism of action of EtOH on
NSC.
CD133, a 5-trans-membrane glycoprotein (Miraglia et al.,
1997) and nestin, have been used as markers to conﬁrm the
undifferentiated state of NSC and to isolate NSC from a
heterogeneous population of cells by our group and others
(Tamaki et al., 2002; Uchida et al., 2000; Vangipuram and
Lyman, 2010; Vangipuram et al., 2008). In this study, we
utilized the expression of CD133 to positively select NSC
from second trimester fetal human brain and study the effects
of EtOH on those cells while differentiating on laminin ⁄ lysine
coated plates.
Although the teratogenic potential of EtOH has been
known for more than 30 years (Jones et al., 1973, 1974a,b),
neither the most vulnerable cell population in the developing
brain nor the exact mechanism of action of EtOH on the
developing fetus have been identiﬁed.
Several mechanisms have been proposed to explain the
teratogenic action of EtOH. A number of groups, including
ours, have suggested that EtOH alters CAM expression.
Min˜ana and colleagues (2000) have shown that EtOH alters
the pattern of NCAM expression during brain development,
whereas Bearer and colleagues (1999) have suggested a possi-
ble L1-mediated inhibition of neurite outgrowth by EtOH.
TGF-b induced NCAM expression has been shown to be
inhibited by EtOH (Luo and Miller, 1999). Alcohol induced
oxidative stress leading to cell death and damage has been
proposed as another possible mechanism of action (Guerri,
1998; Henderson et al., 1995; Kotch et al., 1995). Alterations
to DNA metabolism (Dreosti et al., 1981; Pennington et al.,
1983; Shibley and Pennington, 1997) has been suggested as
yet another possible mechanism. Others include, changes in
energy and glucose metabolism (Mann et al., 1975; Miller
and Dow-Edwards, 1993; Vingan et al., 1986) and altera-
tions in growth factor mediated pathways as shown by sev-
eral groups including those of Jones, Guerri and others
Table 2. Pathways Significantly Impacted by Ethanol in Differentiating Neural Stem Cells Determined by Pathway Analysis Software
Pathway
Genes
involved
Impact factor p-Value
FB 1 FB 2 FB 3 FB 1 FB 2 FB 3
Axon guidance ROBO1
NRCAM
PTN
SOD1
15.99 10.44 6.57 5.35E-07 1.2E-04 0.010
Hedgehog signaling HDAC4
HEY1
PBX4
ROBO1
PTN
5.48 9.12 7.07 0.0078 1.9E-04 8.4E-04
TGF-b signaling HDAC4
SOX3
NRCAM
MT3
EP300
4.99 11.67 3.48 0.017 2.3E-05 0.07
Cell adhesion molecules PCDH1
NCKP1
NRCAM
HDAC4
8.1 10.44 3.01 0.038 0.028 0.01
Wnt signaling HEY1
PBX4
PCDH1
ACHE
EP300
9.45 10.12 3.84 7.88E-05 2.1E-04 0.012
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(Alfonso-Loeches and Guerri, 2011; Hicks and Miller, 2011;
Jones, 2011). Several studies over the past 2 decades have
suggested that prenatal alcohol has a direct effect on progeni-
tor and stem cell populations of the developing brain (Guerri
et al., 1990; Miller, 1989; Miller and Nowakowski, 1991;
Sathyan et al., 2007; Vangipuram and Lyman, 2010; Van-
gipuram et al., 2008). These studies taken together suggest
that EtOH possibly alters multiple pathways simultaneously
leading to the signs of FASD. Further, in the developing
brain EtOH could also have independent and sometimes
even opposing effect on the different cell types. Considering
the crucial role played by NSC and their multipotency, as a
ﬁrst step we chose to use human CD133+ cells to study the
effect of EtOH. Next, we chose to use an Oligo GEArray
analysis method to screen for the changes in various differen-
tiation and neurogenesis-related transcripts to identify possi-
ble pathways affected by EtOH in human NSC.
We exposed NSC to 100 mM EtOH for 96 hours under
differentiating conditions as has been done previously in cell
culture experiments (Prock and Miranda, 2007; Tateno et al.,
2005; Vangipuram and Lyman, 2010; Vangipuram et al.,
2008). A lower 20 mM dose of EtOH was also used in subse-
quent experiments to determine Wnt protein expression by
Western blot.
Oligo GEArray Human Neurogenesis and Neural Stem
Cell Microarrays have previously been used by other groups
to study the changes in gene expressions in differentiating
stem cells (Greco and Rameshwar, 2007). Our microarray
data show that 22 genes were either up- or down-regulated by
EtOH in differentiating NSC (Table 1) which were deter-
mined to have a high impact on 5 crucial pathways ⁄cellular
processes (Table 2). It is interesting that each of the 5 path-
ways ⁄cellular processes affected by EtOH is independently
essential for normal development of fetal brain. A similar
A
B
Fig. 2. (A) Representative Western blot analysis of Wnt signaling protein
expression in differentiating neural stem cells (NSC) exposed to 0, 20, or
100 mM ethanol (EtOH). C: Control NSC; 20: NSC exposed to 20 mM
EtOH for 96 hours; 100: NSC exposed to 100 mM EtOH for 96 hours. (B)
Band densitometry of Wnt signaling proteins: ratios of band intensities rela-
tive to b-actin expression (n = 3). Asterisks indicate a statistically significant
difference in the mean densities compared with controls (*p < 0.05).
B
A
DVL2
DVL3
Fig. 3. (A) Representative Western blot analysis of Wnt receptor com-
plex protein expression in differentiating neural stem cells (NSC) exposed to
0, 20, or 100 mM ethanol (EtOH). C: Control NSC; 20: NSC exposed to
20 mM EtOH for 96 hours; 100: NSC exposed to 100 mM EtOH for
96 hours. (B) Band densitometry of Wnt receptor complex proteins: ratios of
band intensities relative to b-actin expression (n = 3). Asterisks indicate a
statistically significant difference in the mean densities compared with con-
trols (*p < 0.05).
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observation has been made by Hashimoto-Torii and col-
leagues (2011) who have recently shown that multiple path-
ways are altered by alcohol exposure in fetal human cerebral
cortex in vitro including the Wnt signaling and TGF-b signal-
ing pathways.
Axon Guidance. Axon guidance is an important stage
in neuronal network formation. Several factors are involved
in guidance of axons such as netrins, ephrins, slits, and sem-
aphorins (Yu and Bargmann, 2001). These cues are read by
growth cone receptors, and subsequently the signal transduc-
tion pathways downstream of these receptors bring changes
in cytoskeletal organization that determines the direction of
growth. It has been suggested prenatal EtOH disrupts the
outgrowth of axons and dendrites in the development of rat
hippocampus. Furthermore, Lindsley et al. (2003, 2006) have
shown that prenatal EtOH retards initial axon outgrowth,
but accelerates subsequent axon growth suggesting that EtOH
may disrupt the axonal response to guidance cues. In our
study with human NSC, we ﬁnd that EtOH signiﬁcantly
alters the axon guidance pathway. It is possible that these
early effects of EtOH on NSC could be responsible for the
subsequent disruption in the axonal guidance (Table 2).
Hedgehog Pathway. The hedgehog proteins play an
important role in the vertebrate embryogenesis and fetal
development. Of the 3 hedgehog morphogens, sonic hedgehog
(Shh), Desert hedgehog (Dhh), and Indian hedgehog (Ihh),
Shh is known to play an important role not only in ventral
patterning of the neural tube but also in determining the
dopaminergic and seratoninergic cell fates of neural plate
(Charytoniuk et al., 2002). Several studies have shown that
EtOH directly alters the Shh pathway in developing fetal
brain in vivo. Ahlgren and colleagues (2002) have shown that
EtOH induced cell death in neural crest cells is rescued by
Shh in chick embryos. Other studies in mice have shown that
fetal alcohol exposure impairs Shh signaling (Chrisman et al.,
2004; Li et al., 2007; Loucks and Ahlgren, 2009; Yamada
et al., 2005). Our microarray analysis showed that EtOH
exposure to differentiating human NSC signiﬁcantly disrupts
Shh signaling (Table 2). It is possible that the early disruption
of Shh pathway could lead to the neural crest cell death seen
in FASD.
TGF-b Signaling. The transforming growth family
members include several cytokines such the TGF-bs, activins,
and bone morphogenetic proteins. Several functions have
been attributed to the TGFs including, cell proliferation, dif-
ferentiation, and migration. Yi and colleagues (2010) have
shown that TGF-b signaling speciﬁes axons during brain
development in mice in vivo and that TGF-b receptors are
expressed during development. Recently, Hicks and Miller
(2011) have shown that EtOH-induced apoptosis in stem cells
is mediated by both TGF-b dependent and independent
mechanisms. Kuhn and Sarkar (2008) have shown that EtOH
induces apoptotic death of endorphin neurons in rat by a
TGF-b dependent mechanism. A disruption of TGF-b signal-
ing is seen in our study with human NSC and EtOH which
could be a part of the mechanism of action of EtOH.
Cell Adhesion Molecules. CAMs are cell surface glyco-
proteins which play a vital role in several cellular processes
including embryogenesis and fetal neural development. Sev-
eral studies have shown the importance of CAMs in neural
development and that alcohol affects the expression of several
CAMs (Parashar et al., 2010; Sakata-Haga et al., 2003; Sie-
genthaler and Miller, 2004). We suggest based on our micro-
array study that the changes in CAMs begin to occur at the
NSC level in human fetal brain exposed to EtOH. Although
all the above pathways appear to be affected by EtOH in
human NSC, an in-depth study of the various molecules in
each pathway is warranted to elucidate the exact mechanism
of action of EtOH. In this study, we chose to investigate the
effects of EtOH on the Wnt signaling pathway proteins in dif-
ferentiating human NSC.
Wnt Signaling Pathway. Several functions have been
attributed to Wnt signaling in neuronal development as
reviewed by Ille and Sommer (2005). Wnts are secreted palmi-
toylated glycoproteins, which besides playing a key role in
progenitor and stem cell expansion and maintenance also play
a major role in differentiation processes leading to lineage
decisions and in migration, axon guidance, and neurite out
growth. Several studies have implicated Wnt signaling in the
normal fetal brain development and neurogenesis. McMahon
and Bradley (1990) have shown that ablation of Wnt1 pro-
tein caused deﬁciencies in the mid-hind brain formation in
mice, Lee and colleagues suggest that Wnt3a is crucial in the
development of the hippocampus and Wnt3, -3a, -7b, and -8b
participate in the normal development of forebrain (Lee et al.,
2000; Toledo et al., 2008). Severe murine phenotypes were
observed with ablation or overexpression of Wnt proteins in
mice (van Amerongen and Berns, 2006). Haegele and col-
leagues (2003) have shown that inhibition of Wnt signaling
proteins impaired the differentiation of stem cells. Singh and
colleagues (2009) have shown involvement of Wnt proteins in
the impaired neurogenesis seen in pups when pregnant rats
were administered EtOH (Singh et al., 2009). Neznanova and
colleagues (2009) have shown that EtOH increased GSK3b
and AKT phosphorylation in the tissue from medial prefron-
tal cortex suggesting a role for the Wnt signaling pathway in
the action of EtOH.
The Wnts bind to cell surface receptors activating signaling
cascades that follow 3 major pathways: (i) the Wnt ⁄b-catenin
pathway, the canonical Wnt signaling pathway, in which b-
catenin is a crucial member, (ii) the Frizzled ⁄planar cell polar-
ity pathway, and (iii) the Ca2+ pathway (Ku¨hl et al., 2000).
In the Wnt canonical pathway, secreted extra cellular Wnts
bind to a 7 transmembrane FZ proteins and lipoprotein
receptor proteins (LRP) to form a complex. The phosphoryla-
tion of LRPs leads to phosphorylation of Dsh proteins in the
cytoplasm. Dsh proteins when activated by the Wnts inhibit
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GSK3 phosphorylation by forming an axin ⁄GSK3b ⁄APC
complex. This complex when uninhibited promotes proteolytic
degradation of b-catenin. In the presence of Wnt, axin ⁄
GSK3b ⁄APC complex is inhibited promoting a cytoplasmic
pool of b-catenin which enters the nucleus to interact with
TCF ⁄LEF transcription factors to promote speciﬁc gene tran-
scription. In our study, EtOH signiﬁcantly suppressed the
expression of 2 Wnt family proteins, Wnt3a and Wnt5a, both
of which are involved in neurogenesis. Further, Wnt receptor
complex proteins LRP6 andDVL2were also signiﬁcantly sup-
pressed by EtOH in a dose-related manner. However, the Wnt
antagonist NKD-2 and the receptor protein DVL3 were not
affected by EtOH (Fig. 2). This suggests that action of EtOH
is speciﬁc to only some of the pathway proteins. Next, we stud-
ied the expression of inactive Ser phosphorylated GSK3b and
active Tyr phosphorylatedGSK3b. GSK3b is a multifunction-
al Ser-thr enzyme and plays a key role in several pathways
including the Wnt signaling pathway. It plays an important
role in the development of the central nervous system, regulat-
ing diverse early events, including neurogenesis, neuronal
migration, cell adhesion, synapse formation, neuronal survival,
and neurite outgrowth. GSK3b is particularly abundant in the
developing nervous system and has been implicated in EtOH-
induced neurotoxicity in vivo (Luo, 2009). In this study, we
ﬁnd that EtOH suppressed the Ser phosphorylation of GSK3b
in both doses tested and simultaneously signiﬁcantly increased
Tyr phosphorylation leading to increased b-catenin phosphor-
ylation (Fig. 3). Phosphorylated b-catenin undergoes immedi-
ate proteosomal degradation and ubiquitination. As expected,
the levels unphosphorylated b-catenin were signiﬁcantly sup-
pressed by EtOH (Fig. 3). A similar reduction in b-catenin lev-
els in EtOH exposed neural crest progenitors has recently been
reported by Flentke and colleagues (2011) who have further
shown that normalizing b-catenin levels prevents neural crest
loss. Lange and colleagues (2011) suggest that small molecule
GSK3 inhibitors increase neurogenesis of human neural pro-
genitor cells. Recent studies show that lithium, aGSK3b inhib-
itor, protects against EtOH neurotoxicity (Luo, 2009). As we
show that EtOH has a direct effect on the Ser ⁄Tyr phosphory-
lation of GSK3b in human cells, in vivo studies to reverse
FASD in animalmodels using small moleculeGSK3 inhibitors
could shed light on possible future therapies.
We infer from our current data, that EtOH signiﬁcantly
alters at least 5 major pathways ⁄cellular processes involved in
neuronal development in differentiating NSC. Further, EtOH
suppresses Wnt signaling pathway proteins that are involved
in speciﬁc gene transcription in brain development. These
ﬁndings could be a signiﬁcant step in elucidation of the mech-
anism of action of EtOH on the developing brain. Future in
vivo and in vitro studies using GSK3b inhibitors could lead
to possible therapeutic interventions.
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